A comparison of the behavioral effects of oral versus intravenous mCPP administration in OCD patients and the effect of metergoline prior to IV mCPP

Identification and distribution of 5-HT3 receptors in rat brain using radioligand binding

1987 • 866 citations

Functional Correlates of Serotonin 5-HT₁Recognition Sites

1988 • 564 citations

Clomipramine Treatment of Obsessive-Compulsive Disorder

1980 • 492 citations

Serotonergic Responsivity in Obsessive-Compulsive Disorder

1987 • 378 citations

Obsessive Compulsive Disorder

2022 • 305 citations

Evidence that mCPP may have behavioural effects mediated by central 5‐HT_1C receptors

1988 • 299 citations

Serotonergic Responsivity in Obsessive-Compulsive Disorder

1988 • 299 citations

Anxiogenic-like effects of mCPP and TFMPP in animal models are opposed by 5-HT1C receptor antagonists

1989 • 285 citations

Serotonergic Function in Obsessive-Compulsive Disorder

1992 • 263 citations

Serotonin Function in Obsessive-Compulsive Disorder

1988 • 237 citations

1-(m-Chlorophenyl)piperazine (mCPP) interactions with neurotransmitter receptors in the human brain

1989 • 229 citations

The Influence of Ritanserin, a Serotonin Antagonist, in Anxiety Disorders: A Double-blind Placebo-controlled Study versus Lorazepam

1985 • 223 citations

Controlled Comparisons of Clomipramine and Fluoxetine in the Treatment of Obsessive-Compulsive Disorder

1990 • 218 citations

Serotonin-selective arylpiperazines with neuroendocrine, behavioral, temperature, and cardiovascular effects in humans.

1991 • 216 citations

Comparative anxiogenic, neuroendocrine, and other physiologic effects of m-chlorophenylpiperazine given intravenously or orally to healthy volunteers

1989 • 202 citations

Clomipramine in Obsessive-Compulsive Disorder

1989 • 151 citations

Further studies of the putative serotonin agonist, m-chlorophenylpiperazine: Evidence for a serotonin receptor mediated mechanism of action in humans

1986 • 142 citations

Serotonergic and noradrenergic sensitivity in obsessive-compulsive disorder: behavioral findings

1988 • 140 citations

Effects of chronic fluoxetine treatment on behavioral and neuroendocrine responses to meta-chloro-phenylpiperazine in obsessive-compulsive disorder

1991 • 121 citations

Metergoline blocks the behavioral and neuroendocrine effects of orally administered m-chlorophenylpiperazine in patients with obsessive-compulsive disorder

1991 • 114 citations

1-Methyl-8 β-carbobenzyloxy-aminomethyl-10 α-ergoline, a Potent and Long-lasting 5-Hydroxytryptamine Antagonist

1965 • 107 citations

Effects of ritanserin on the behavioral, neuroendocrine, and cardiovascular responses to meta-chlorophenylpiperazine in healthy human subjects

1991 • 102 citations

Neuropsychiatric disorders and the multiple human brain serotonin receptor subtypes and subsystems.

1990 • 100 citations

m-CPP: a tool for studying behavioural responses associated with 5-HT1c receptors

1990 • 92 citations

Hyperresponsivity to the Serotonin Agonist m-Chlorophenylpiperazine in Alzheimer's Disease

1989 • 91 citations

The Interaction of the Serotonergic and Dopaminergic Systems on Prolactin Secretion in the Rat: The Mechanism of Action of the “Specific” Serotonin Receptor Antagonist, Methysergide*

1978 • 83 citations

Metergoline as a selective 5-hydroxytryptamine antagonist in the cerebral cortex

1977 • 82 citations

Effects of serotonin antagonists on m-chlorophenylpiperazine-mediated responses in normal subjects

1990 • 50 citations

On the Mode of the Prolactin Release-Inhibiting Action of the Serotonin Receptor Blockers Metergoline, Methysergide, and Cyproheptadine*

1981 • 50 citations

Interaction of metergoline with striatal dopamine system

1978 • 28 citations

Pharmacological Treatment of Obsessive Compulsive Disorder

1989 • 23 citations

Hypersensitivity to m-chlorophenylpiperazine in a subject with subclinical panic attacks

1990 • 17 citations

Competitive Interaction of Agonists and Antagonists with 5-HT₃-Recognition Sites in Membranes of Neuroblastoma Cells Labelled with [3H] ICS 205–930

1989 • 14 citations

Social signalling and schizophrenia: The significance of neurochemical and morphological abnormalities of the basolateral circuit

1991 • 9 citations

Serotonin receptor sensitivity in schizophrenia

1991 • 1 citations